New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 8, 2014
07:20 EDTNEONeoGenomics to be primary partner with Aurora Diagnostics for molecular testing
NeoGenomics announced that it has been selected by Aurora Diagnostics to be its primary partner for molecular testing at each of Aurora's 19 specialized anatomic pathology laboratories in the United States. As a result of this alliance, Aurora will be able to standardize advanced oncology-focused molecular testing services to support the needs of their referring physicians.
News For NEO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 23, 2015
07:51 EDTNEONeoGenomics lowers FY15 revenue guidance to 100M-$103M from $103M-$108M
Consensus $103.78M. NeoGenomics reiterated its expectation of a return to profitability in the second half of 2015.
07:21 EDTNEONeoGenomics reports Q2 EPS 0c, consensus (1c)
Subscribe for More Information
July 22, 2015
07:09 EDTNEONeoGenomics expands multimodality cancer profile testing
NeoGenomics expanded its comprehensive multimodality NeoTYPE tumor-type specific cancer profiling tests to include new profiles for head and neck tumors, pancreatic cancer, liver cancer, sarcoma, and for cancers of unknown primary. These new tests integrate a variety of technologies, including next generation sequencing, viral in-situ hybridization, FISH, and immunohistochemistry. A number of new tests are being added to NeoGenomics cancer diagnostic test menu.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use